Astellas US LLC et al v. Baxter Healthcare Corporation > Summary
Court Case Number 1:22-cv-01390
Filing Date Oct 24, 2022
Termination Date May 1, 2023
Court Delaware District Court
Status Dismissed - Other
JudgesColm F. Connolly
Defendant
Plaintiff Attorneys
12Gilead Sciences
Attorney Name: Robert M. Oakes
Fish & Richardson
Gilead Sciences
Attorney Name: Kelly A. Del Dotto
Fish & Richardson
Gilead Sciences
Attorney Name: Chad Shear
Fish & Richardson
Gilead Sciences
Attorney Name: Robert M. Oakes
Fish & Richardson
Gilead Sciences
Attorney Name: Kelly A. Del Dotto
Fish & Richardson
Gilead Sciences
Attorney Name: Chad Shear
Fish & Richardson
Gilead Sciences
Attorney Name: Robert M. Oakes
Fish & Richardson
Gilead Sciences
Attorney Name: Kelly A. Del Dotto
Fish & Richardson
Gilead Sciences
Attorney Name: Chad Shear
Fish & Richardson
Gilead Sciences
Attorney Name: Chad Shear
Cooley LLP
Gilead Sciences
Attorney Name: Chad Shear
Cooley LLP
Gilead Sciences
Attorney Name: Chad Shear
Cooley LLP
Defendant Attorneys
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| RE047301 | Process for preparing an A2A-adenosine receptor agonist and its polymorphs | Mar 19, 2019 |
| 08524883 | Monohydrate of (1-{9-[4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-aminopurin-2-yl}pyrazol-4-yl)-N-methylcarboxamide | Sep 3, 2013 |
| 08106183 | Process for preparing an A2A-adenosine receptor agonist and its polymorphs | Jan 31, 2012 |
